Literature DB >> 8058651

Effect of hepatic cirrhosis on the pharmacodynamics and pharmacokinetics of mivacurium in humans.

G Levy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058651     DOI: 10.1023/a:1018901018438

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  2 in total

Review 1.  Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.

Authors:  D J Morgan; A J McLean
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

2.  Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models.

Authors:  Meindert Danhof
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-30       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.